Annual Current Ratio
5.14
-4.28-45.44%
31 December 2023
Summary:
Aprea Therapeutics annual current ratio is currently 5.14, with the most recent change of -4.28 (-45.44%) on 31 December 2023. During the last 3 years, it has fallen by -2.59 (-33.51%). APRE annual current ratio is now -64.99% below its all-time high of 14.68, reached on 31 December 2019.APRE Current Ratio Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Quarterly Current Ratio
7.28
-2.27-23.77%
30 September 2024
Summary:
Aprea Therapeutics quarterly current ratio is currently 7.28, with the most recent change of -2.27 (-23.77%) on 30 September 2024. Over the past year, it has increased by +2.14 (+41.63%). APRE quarterly current ratio is now -50.41% below its all-time high of 14.68, reached on 31 December 2019.APRE Quarterly Current Ratio Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
APRE Current Ratio Performance
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly |
|---|---|---|
| 1 y1 year | - | +41.6% |
| 3 y3 years | -33.5% | -5.8% |
| 5 y5 years | -65.0% | -50.4% |
APRE Current Ratio High & Low
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | |
|---|---|---|---|---|---|
| 3 y | 3 years | -45.4% | at low | -34.7% | +41.6% |
| 5 y | 5 years | -65.0% | at low | -50.4% | +41.6% |
| alltime | all time | -65.0% | -50.4% | +41.6% |
Aprea Therapeutics Current Ratio History
| Date | Annual | Quarterly |
|---|---|---|
| Sept 2024 | - | 7.28(-23.8%) |
| June 2024 | - | 9.55(-14.3%) |
| Mar 2024 | - | 11.15(+116.9%) |
| Dec 2023 | 5.14(-45.4%) | 5.14(-16.4%) |
| Sept 2023 | - | 6.15(-15.2%) |
| June 2023 | - | 7.25(-4.2%) |
| Mar 2023 | - | 7.57(-19.6%) |
| Dec 2022 | 9.42(+21.9%) | 9.42(+12.5%) |
| Sept 2022 | - | 8.37(+58.8%) |
| June 2022 | - | 5.27(-29.3%) |
| Mar 2022 | - | 7.45(-3.6%) |
| Dec 2021 | 7.73 | 7.73(+12.4%) |
| Sept 2021 | - | 6.88(+2.2%) |
| June 2021 | - | 6.73(-5.7%) |
| Date | Annual | Quarterly |
|---|---|---|
| Mar 2021 | - | 7.14(+18.4%) |
| Dec 2020 | 6.03(-58.9%) | 6.03(-19.5%) |
| Sept 2020 | - | 7.49(-4.9%) |
| June 2020 | - | 7.88(-27.0%) |
| Mar 2020 | - | 10.79(-26.5%) |
| Dec 2019 | 14.68(+8.3%) | 14.68(+148.0%) |
| Sept 2019 | - | 5.92(-45.5%) |
| June 2019 | - | 10.87(-19.8%) |
| Dec 2018 | 13.56(+135.8%) | 13.56 |
| Dec 2017 | 5.75(>+9900.0%) | - |
| June 2008 | 0.01(-93.3%) | - |
| June 2007 | 0.15(+87.5%) | - |
| June 2006 | 0.08(>+9900.0%) | - |
| Dec 2004 | 0.00 | - |
FAQ
- What is Aprea Therapeutics annual current ratio?
- What is the all time high annual current ratio for Aprea Therapeutics?
- What is Aprea Therapeutics quarterly current ratio?
- What is the all time high quarterly current ratio for Aprea Therapeutics?
- What is Aprea Therapeutics quarterly current ratio year-on-year change?
What is Aprea Therapeutics annual current ratio?
The current annual current ratio of APRE is 5.14
What is the all time high annual current ratio for Aprea Therapeutics?
Aprea Therapeutics all-time high annual current ratio is 14.68
What is Aprea Therapeutics quarterly current ratio?
The current quarterly current ratio of APRE is 7.28
What is the all time high quarterly current ratio for Aprea Therapeutics?
Aprea Therapeutics all-time high quarterly current ratio is 14.68
What is Aprea Therapeutics quarterly current ratio year-on-year change?
Over the past year, APRE quarterly current ratio has changed by +2.14 (+41.63%)